Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...

In 2023, cervical cancer screening rates still remained below prepandemic levels, new survey data suggested. However, screening rates for breast and colorectal cancers rebounded from pandemic declines ...

Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round Patients having both a cancer registry ...

Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...